Sana Biotechnology Inc
(NAS:SANA)
$
4.3
-0.06 (-1.38%)
Market Cap: 956.60 Mil
Enterprise Value: 816.87 Mil
PE Ratio: 0
PB Ratio: 2.81
GF Score: 38/100 Sana Biotechnology Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 09:20PM GMT
Release Date Price:
$6.11
(+10.29%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the afternoon sessions of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here. And we're thrilled to have Sana Biotechnology, and then we have Steve Harr, President and CEO on stage with us. Steve, welcome.
Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director
Thank you, Geoff. Thank you for having us. Appreciate it.
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Every second counts, I got a 15 minutes spot. So why don't I just turn it you give us like the 2-minute kind of background, and we'll get ready to some questions.
Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director
Sure. First off, we'll make some forward-looking statements, and we filed our Q last night, and we spent a lot of time on risk factors, so take a look. There's a lot of good information in there.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot